Novartis Pharmaceuticals (NVS.US) Q1 performance exceeds expectations, raises full-year growth target.

According to the Securities Times app, Swiss pharmaceutical company Novartis (NVS.US) announced better-than-expected first-quarter sales on Tuesday and raised its full-year performance guidance.